Brief: Richter Says Consolidated Sales For H1 Was 413,436 HUF Mln Versus 360,980 HUF Mln
Aug 4 (Reuters) - Richter Gedeon Vegyeszeti Gyar Nyrt
GDRB.BU :
* CONSOLIDATED SALES FOR H1 TOTAL 413,436 HUF MILLION VERSUS
360,980 HUF MILLION
* H1 OPERATING PROFIT 95,013 MILLION HUF VERSUS 89,455
MILLION HUF
* RUSSIA PHARMA SALES FOR H1 TOTAL RUSSIA 63,033 HUF MILLION
VERSUS 50,795 HUF MILLION
* H1 PHARMA SALES IN US WAS 95,939 MILLION HUF VERSUS 70,738
MILLION HUF
* WHILE UNDERLYING PROFITABILITY REMAINED SOLID AS REFLECTED
ALSO
IN CASH GENERATION, HEADLINE EARNINGS NUMBERS WERE HIT BY NUMBER
OF ONE-OFF FACTORS IN H1
Source text: https://tinyurl.com/3an9dcpy
Further company coverage: GDRB.BU
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Richter Gedeon Vegyeszeti Gyar Nyrt
See all newsAI in Hungary could unlock productivity gains of €15 billion, McKinsey says
Brief: Hungary's Richter and Hetero announce cooperation for development of semaglutide injection
Brief: Hungary's Richter and Acrux agree to license transdermal Estradiol spray for Australia
Brief: Hungary's Richter Says 2026 Guidance Fully Reiterated High-Single-Digit Growth In Revenues And Clean EBIT (At Constant Exchange Rates)
Brief: Hungary's Richter says European Commission granted approval for Tuyory, its biosimilar to Tocilizumab